Sequential determination of iron(II) and iron(III) in pharmaceutical by flow-injection analysis with spectrophotometric detection.

Abstract

A flow injection procedure for the sequential spectrophotometric determination of iron(II) and iron(III) in pharmaceutical products is described. The method is based on the catalytic effect of iron(II) on the oxidation of iodide by bromate at pH = 4.0. The reaction was monitored spectrophotometrically by measuring the absorbance of produced triiodide ion at 352 nm. The activating effect for the catalysis of iron(II) was extremely exhibited in the presence of oxalate ions, while oxalate acted as a masking agent for iron(III). The iron(III) in a sample solution could be determined by passing through a Cd-Hg reductor column introduced in the FIA system to reduce iron(III) to iron(II), which allows total iron determination. Under the optimum conditions, iron(II) and iron(III) could be determined over the range of 0.05 - 5.0 and 0.10 - 5.0 microg ml(-1), respectively with a sampling rate of 17 +/- 5 h(-1). The experimental limits of detection were 0.03 and 0.04 microg ml(-1) for iron(II) and iron(III), respectively. The proposed method was successfully applied to the speciation of iron in pharmaceutical products.